Cruz-del Castillo AH, García-Fierro R, Hess-Moreno MI, Vigil-Pérez CA, Córdova-Fernández JA, Chuck-Santiago MP, Hernández-Cruz SL, Sánchez-Rodríguez A

Language: Spanish
References: 11
Page: 164-169
PDF size: 578.25 Kb.

ABSTRACT

Introduction The increase on life expectancy of the population, life style changes and diet has placed the non- transmissible chronic diseases as the first cause of death, deteriorating the population’s quality of life and generating important costs to the health care system. The information about the clinical characteristics and the prevalence of metabolic syndrome in blood donors is limited.
Material and methods It is a retrospective descriptive study performed in a population group including 726 blood donor subjects who attended General Hospital Zone 36’s Blood bank of the Instituto Mexicano del Seguro Social (IMSS) during the period corresponding to July 2010 to July 2011. The variables analyzed were serum glucose fasting, (SG), total cholesterol, HDL cholesterol fractions, triglycerides, blood pressure (BP) BMI, waist (WC) and hip ( HC) circumference. The statistical analysis included tests with measures of central tendency and spreading, relative and absolute frequencies. Were included quantitative variables analyzed through parametric tests, Student’s T. The qualitative variables analyzed through non-parametric statistics included Chi-square test. The risk was calculated by thee obtaining of ratios of variables adjusted by gender. The statistical analysis was done with Statistical software SPSS version 17.0.
Results The average age was 32.2 ± 10 years old, 86.2% male. The average levels of glycaemia was 103.8 ± 19.7; HDL cholesterol: 32.03 ± 9.9 mg/dL; triglycerides: 227.39 ± 160.3 mg/dL; weight: 81.6 ± 14.1kg; size: 1.66 ± 0.07m; BMI: 29.3 ± 4.43 Kg/m2; WC: 94.2 ± 10.6 cm; HC: 103 ±7.9 cm. The prevalence of fasting altered glucose was 54.8% (398 patients); 16.9% displayed low levels of HDL, 63.2% had hypertriglyceridemia and 44.1% abdominal obesity. The total prevalence of metabolic syndrome was 54.4%. Being male conferred 2.2 OR to the development of metabolic syndrome (IC 95% 1.44-3.60).
Conclusions The type of population included on the study is characterized by qualifying as fitting for blood donation. However, was found the unexpected prevalence of cardiometabolic risk factors and thus, a high prevalence of metabolic syndrome on subjects without a diagnosis prior the study, evidencing the need for investment on programs for the timely detection and prevention of triggering factors of this syndrome.

REFERENCES

1. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002; 287:356-359.

2. Rivera JA, Barquera S, Gonzalez-Cossio T, Olaiz G, Sepulveda J. Nutrition transition in Mexico and in other Latin American countries. Nutr Rev. 2004; 62:S149-S157.

3. Stevens G, Dias RH, Thomas KJ, Rivera JA, Carvalho N, Barquera S, Hill K, Ezzati M. Characterizing the epidemiological transition in Mexico: national and subnational burden of diseases, injuries, and risk factors. PLoS Med. 2008; 5:e125.

4. Barquera S, Campirano F, Bonvecchio A, Hernandez- Barrera L, Rivera JA, Popkin BM. Caloric beverage consumption patterns in Mexican children. Nutr J. 2010; 9:47

5. Barquera S, Campos-Nonato I, Hernandez-Barrera L, Flores M, Durazo-Arvizu R, Kanter R, Rivera JA. Obesity and central adiposity in Mexican adults: results from the Mexican National Health and Nutrition Survey 2006. Salud Publica Mex 2009; 51 Suppl 4:S595-S603.

6. Barquera S, Campos-Nonato I, Hernandez-Barrera L, Flores M, Durazo-Arvizu R, Kanter R, Rivera JA. Obesity and central adiposity in Mexican adults: results from the Mexican National Health and Nutrition Survey 2006. Salud Publica Mex 2009; 51 Suppl 4:S595-S603.

7. Sarafidis PA, Nilsson PM. The metabolic syndrome: a glance at its history. J.Hypertens. 2006; 24:621-626

8. Alberti KG, Zimmet P, Shaw J. Metabolic syndrome-- a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med 2006; 23:469-480.

9. Cordova-Villalobos JA, Barriguete-Melendez JA, Lara-Esqueda A, Barquera S, Rosas-Peralta M, Hernandez-Avila M, Leon-May ME, Admon L, Aguilar-Salinas CA. Las enfermedades cronicas no transmisibles en Mexico: sinopsis epidemiologica y prevencion integral. Salud Publica Mex 2008; 50:419- 427.

10. 10.Padierna-Luna JL, Ochoa-Rosas FS, Jaramillo- Villalobos B. [Prevalence of metabolic syndrome in health employees]. Rev Med Inst Mex Seguro Soc 2007; 45:593-599.

11. Munguia-Miranda C, Sanchez-Barrera RG, Tuz K, Alonso-Garcia AL, Cruz M. [Impaired fasting glucose detection in blood donors population]. Rev Med Inst Mex Seguro Soc 2009; 47:17-24.